Diabetic Footwear Market - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Diabetes is a chronic disease caused by lack or lower levels of insulin in the body. A person suffering from diabetes may develop sores, abscesses, ulcers, or loss of sensation in parts of the body, predominantly in feet. The exceptional design of diabetic footwear aids in protecting the patient’s feet from injuries. According to World Health Organization (WHO), in 1980, the number of diabetic patients was108 Mn, which in reached 422 Mn in 2014. Primary reason behind this growth in number is the busy lifestyle of urban society along with increased intake of sugar and other artificial sweeteners. Unique properties of diabetic footwear help heal a variety of diabetic conditions such as inadequate blood circulation to legs and thus, help address foot pain and ulcers. Diabetes is classified as Type 1, Type 2, and gestational diabetes. Type 2 diabetes, the most common type, is caused mainly due to obesity and reduced physical activity. Global diabetic footwear market is largely driven by the rising cases of diabetes, increased spending on diabetes treatment, and growing geriatric population, characterized by high incidence of diabetes. Request For Sample Copy of this Research Report : https://www.coherentmarketinsights.com/insight/request-sample/744 Men were the biggest end users of diabetic footwear globally in 2016. According to a report by National Health Service, males are more prone to diabetes and need to gain far less weight than females to develop the disease. However, women are expected to be the fastest growing end users of diabetic footwear during the forecast period. Diabetic footwear products include sandals, shoes, and slippers. Availability of diabetic footwear in different models gained them wide acceptance among the public for use in any occasion. Asia Pacific is the most dominant region in the global diabetic footwear market. According to National Center for Biotechnology Information, around 150 Mn diabetic patients reside in this region, with over 95% diagnosed with Type 2 diabetes. The region accounted for 36.30% of the total market share in 2016, in terms of revenue. The dominance is on account of the large population suffering from diabetes coupled with an increase in expenditure on diabetes treatment and rise in the size of geriatric population. China and India are home to one-third of the total global population with India being dubbed as ‘The Diabetes Capital of the World’. Increase in disposable